Comparing Movantik vs Symproic
| Movantik (naloxegol) | Symproic (naldemedine) |
|
|---|
| Movantik (naloxegol) | Symproic (naldemedine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Opioid-Induced Constipation, Constipation - Chronic, Constipation - Drug Induced. Movantik may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Opioid-Induced Constipation. Symproic may also be used for purposes not listed in this medication guide. |
Related suggestions Opioid-Induced Constipation
Popular comparisons
|
|||||||||||||||
| More about Movantik (naloxegol) | More about Symproic (naldemedine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Movantik has an average rating of 4.9 out of 10 from a total of 265 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 47% reported a negative effect. |
Symproic has an average rating of 6.4 out of 10 from a total of 34 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Movantik side effects |
View all Symproic side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Movantik prices |
View all Symproic prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
11 hours |
11 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 242 drugs are known to interact with Movantik:
|
A total of 179 drugs are known to interact with Symproic:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 16, 2014 |
March 23, 2017 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Amitiza
Amitiza (lubiprostone) is used to treat chronic constipation and irritable bowel syndrome with ...
GoLYTELY
GoLYTELY is used for bowel preparation, constipation, chronic, gastrointestinal decontamination
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
GaviLyte-G
GaviLyte-G is used for bowel preparation, constipation, chronic, gastrointestinal decontamination
Constulose
Constulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Relistor
Relistor reduces constipation caused by narcotic medications used to treat pain in people with ...
Enulose
Enulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Suflave
Suflave is a combination, osmotic, prescription laxative that may be used to cleanse the bowel in ...
PEG-3350 with Electolytes
PEG-3350 with Electolytes is used for bowel preparation, constipation, chronic, gastrointestinal ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.